JP2021535895A5 - - Google Patents

Info

Publication number
JP2021535895A5
JP2021535895A5 JP2020570515A JP2020570515A JP2021535895A5 JP 2021535895 A5 JP2021535895 A5 JP 2021535895A5 JP 2020570515 A JP2020570515 A JP 2020570515A JP 2020570515 A JP2020570515 A JP 2020570515A JP 2021535895 A5 JP2021535895 A5 JP 2021535895A5
Authority
JP
Japan
Prior art keywords
dimethanobenzo
hexahydro
methyl
urea
annulen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020570515A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021535895A (ja
JP7442828B2 (ja
Filing date
Publication date
Priority claimed from EP18382445.7A external-priority patent/EP3584236A1/en
Application filed filed Critical
Publication of JP2021535895A publication Critical patent/JP2021535895A/ja
Publication of JP2021535895A5 publication Critical patent/JP2021535895A5/ja
Application granted granted Critical
Publication of JP7442828B2 publication Critical patent/JP7442828B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020570515A 2018-06-20 2019-06-19 可溶性エポキシド加水分解酵素阻害剤としての多環式化合物 Active JP7442828B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18382445.7 2018-06-20
EP18382445.7A EP3584236A1 (en) 2018-06-20 2018-06-20 Polycyclic compounds soluble epoxide hydrolase inhibitors
PCT/EP2019/066181 WO2019243414A1 (en) 2018-06-20 2019-06-19 Polycyclic compounds as soluble epoxide hydrolase inhibitors

Publications (3)

Publication Number Publication Date
JP2021535895A JP2021535895A (ja) 2021-12-23
JP2021535895A5 true JP2021535895A5 (cg-RX-API-DMAC7.html) 2022-06-27
JP7442828B2 JP7442828B2 (ja) 2024-03-05

Family

ID=62784072

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020570515A Active JP7442828B2 (ja) 2018-06-20 2019-06-19 可溶性エポキシド加水分解酵素阻害剤としての多環式化合物

Country Status (13)

Country Link
US (2) US20210261564A1 (cg-RX-API-DMAC7.html)
EP (2) EP3584236A1 (cg-RX-API-DMAC7.html)
JP (1) JP7442828B2 (cg-RX-API-DMAC7.html)
KR (1) KR102806466B1 (cg-RX-API-DMAC7.html)
CN (1) CN112888674B (cg-RX-API-DMAC7.html)
AU (1) AU2019291034B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020026027A2 (cg-RX-API-DMAC7.html)
CA (1) CA3104342A1 (cg-RX-API-DMAC7.html)
EA (1) EA202190072A1 (cg-RX-API-DMAC7.html)
ES (1) ES2975451T3 (cg-RX-API-DMAC7.html)
IL (1) IL279496A (cg-RX-API-DMAC7.html)
MX (1) MX2020014276A (cg-RX-API-DMAC7.html)
WO (1) WO2019243414A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113831301B (zh) * 2020-06-08 2023-06-06 沈阳药科大学 苯并噻唑类衍生物及其用途
EP4063348A1 (en) 2021-03-24 2022-09-28 Universitat de Barcelona Compounds as soluble epoxide hydrolase inhibitors
WO2024105225A1 (en) 2022-11-18 2024-05-23 Universitat De Barcelona Synergistic combinations of a sigma receptor 1 (s1r) antagonist and a soluble epoxide hydrolase inhibitor (sehi) and their use in the treatment of pain

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210799A1 (de) 1972-03-07 1973-09-20 Basf Ag 5,9:7,11-dimethano-8-hetero-11h-5,6. 7.8.9.10-hexahydro-benzo-cyclononene
DE2261637A1 (de) * 1972-12-16 1974-06-20 Basf Ag 5,8 : 7.10-dimethano-5.6.7.8.9.10-hexa-hydro-benzo-cyclooctene und verfahren zu ihrer herstellung
AU1317000A (en) 1998-10-20 2000-05-08 Boehringer Ingelheim Pharmaceuticals, Inc. Method of treating immunological disorders mediated by t-lymphocytes
WO2003002555A1 (en) 2001-06-29 2003-01-09 Boehringer Ingelheim Pharmaceuticals Inc. Methods of using soluble epoxide hydrolase inhibitors
EP1909796A4 (en) 2005-07-12 2009-11-11 Univ California USE OF EPOXY EICOSATRIC ACIDS AND INHIBITORS OF SOLUBLE EPOXY HYDROLASE FOR THE TREATMENT OF EYE DISEASES
WO2007016496A2 (en) 2005-08-02 2007-02-08 Neurogen Corporation Dipiperazinyl ketones and related analogues
AR059826A1 (es) 2006-03-13 2008-04-30 Univ California Inhibidores de urea conformacionalmente restringidos de epoxido hidrolasa soluble
JP2010521456A (ja) * 2007-03-13 2010-06-24 アレテ セラピューティクス, インコーポレイテッド 可溶性エポキシドヒドロラーゼ阻害剤
US9034903B2 (en) * 2012-02-01 2015-05-19 The Regents Of The University Of California Acyl piperidine inhibitors of soluble epoxide hydrolase
US10813894B2 (en) 2015-02-20 2020-10-27 The Regents Of The University Of California Methods of inhibiting pain
CA2993882A1 (en) 2015-07-28 2017-02-02 Universitat De Barcelona Analogs of adamantylureas as soluble epoxide hydrolase inhibitors
US11123311B2 (en) 2016-01-05 2021-09-21 The Regents Of The University Of California Methods of treating mental disorders

Similar Documents

Publication Publication Date Title
RU2315041C2 (ru) Производные 2,6-хинолинила и 2,6-нафтила, фармацевтические композиции на их основе, их применение в качестве ингибиторов vla-4 и промежуточные соединения
JP2021514001A5 (cg-RX-API-DMAC7.html)
JP2013517283A5 (cg-RX-API-DMAC7.html)
CZ192297A3 (en) Substituted azetidin-2-ones for treating atherosclerosis, process of their preparation and use
RU2011110435A (ru) Пролекарства метилгидрофумарата, фармацетические композиции с ними и способы применения
JP2009538333A5 (cg-RX-API-DMAC7.html)
NZ596071A (en) Oxazole substituted indazoles as pi3-kinase inhibitors
HRP20141048T1 (hr) Spojevi, pripravci i metode
PE20090297A1 (es) Derivados de pirazol sustituidos con heteroarilo utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogenesis
CA2672373A1 (en) Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
JP2023518948A5 (cg-RX-API-DMAC7.html)
JP6463680B2 (ja) 脾臓チロシンキナーゼi(syk)阻害剤としての2−(2−アミノシクロヘキシル)アミノピリミジン−5−カルボキサミド類
JP2025160175A5 (cg-RX-API-DMAC7.html)
PE20051170A1 (es) DERIVADOS DE PIRROL COMO INHIBIDORES DEL FACTOR Xa
JP2007502265A5 (cg-RX-API-DMAC7.html)
JP2019535747A5 (cg-RX-API-DMAC7.html)
JP2010522710A (ja) P2x7調節因子としてのオキサゾリジンおよびモルホリンカルボキサミド誘導体
CN103635466A (zh) 芳族酰胺及其用途
HRP20170338T1 (hr) Fluorometil-supstituirani pirolkarboksamidi
WO2006016637A1 (ja) 新規環状アミノ安息香酸誘導体
JP2005272321A (ja) 含窒素複素環化合物およびその医薬用途
JP2023518474A5 (cg-RX-API-DMAC7.html)
JP2012501334A5 (cg-RX-API-DMAC7.html)
BE1009571A3 (fr) Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant.
US20240400575A1 (en) Polycyclic compounds as soluble epoxide hydrolase inhibitors